McCarter 1998.

Methods	Randomised clinical trial, USA
Participants	112 hospitalised adults with an appropriate clinical indication for PEG, 16 years of age or older, and life expectancy of 30 days or more, at nutritional risk due to trialist indication Male:Female = 63:49 Mean age = 63 years Exclusion: prior gastric surgery, evidence of gastro‐intestinal obstruction, known gastric or small bowel dysmotility, marked ascites, infection or cellultis at the anticipated PEG site, proximal small bowel fistula, neoplastic or infiltrative disease of the gastric wall, morbid obesity, extensive scarring of the anterior abdominal wall, prolonged prothrombin time not correctable to < 3 s of the control value, and platelet count < 50 K
Interventions	Experimental: started enteral feeding (Isocal) through PEG after 4 hours(n = 57) Control: no intervention(n = 55) Co‐intervention: enteral feeding (Isocal) after 24 hrs
Outcomes	Mortality, complications
Study dates	Not stated
Notes	We could find no contact information for the authors.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not described
Allocation concealment (selection bias)	Unclear risk	Not described
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Not described
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not described
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The number of participants with incomplete data was not reported.
Selective reporting (reporting bias)	Low risk	The trial reports mortality and complications.
For‐profit bias	Unclear risk	It was unclear how the trial was funded.
Other bias	Low risk	The trial appeared to be free of other components that could put it at risk of bias.